During the past decade, Marshall Health MARC Program conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marshall Health MARC Program" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 3 trials as a collaborator and "The Emmes Company, LLC" with 3 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Marshall Health MARC Program" are "Drug Abuse" (3 trials), "Drug Abuse in Pregnancy" (3 trials), "Drug Addiction" (3 trials), "Neonatal Abstinence Syndrome" (3 trials) and "Opioid-Related Disorders" (3 trials). Many other conditions were trialed in "Marshall Health MARC Program" in a lesser frequency.

Most popular intervention types in "Marshall Health MARC Program" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Buprenorphine Injection" (3 trials) and "Buprenorphine Sublingual Product" (3 trials). Other intervention names were less common.

The vast majority of trials in "Marshall Health MARC Program" are 2 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Marshall Health MARC Program". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Marshall Health MARC Program, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Marshall Health MARC Program, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".